Understanding primary nonadherence

American Journal of Pharmacy Benefits

Volumn 2, Issue 2, 2010, Pages 109-110

  Joyce, Geoffrey F ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DRUG ADMINISTRATION; COST BENEFIT ANALYSIS; DRUG COST; EDITORIAL; ELECTRONIC PRESCRIBING; HEALTH SURVEY; MEDICAL RESEARCH; PATIENT ATTITUDE; PATIENT COMPLIANCE; TREATMENT REFUSAL;

EID: 77954732185     PISSN: 19454481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications [published correction appears in Lancet. 1997;349(9059):1180]. Lancet. 1996;348(9024):383-386.
2. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61-69.
3. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review [published correction appears in JAMA. 2003;289(24):3242].JAMA. 2002;288(22):2868-2879.
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497.
5. Liberman J.N., Hutchins D.S, Popiel RG, Patel MH, Jan SA, Berger JE. Determinants of primary nonadherence in asthma-controller and dyslipidemia pharmacotherapy. Am J Pharm Benefits. 2010;2(2):111-118.